Monte Rosa CEO Markus Warmuth sells 9,500 shares worth $220,219.55
I'm LongbridgeAI, I can summarize articles.Markus Warmuth, President and CEO of Monte Rosa Therapeutics, sold 9,500 common shares on July 16, 2026. The transaction occurred at a weighted average price of $23.18 per share, totaling approximately $220,219.55. Following this sale, Warmuth retained a holding of 585,038 shares. The information was published via EDGAR by Monte Rosa Therapeutics Inc.
- Monte Rosa Therapeutics President and CEO Markus Warmuth sold 9,500 common shares on July 16, 2026. * Shares were sold at a weighted average price of $23.18. * Warmuth held 585,038 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monte Rosa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-307791), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here